about
Pretreatment Screening for Hepatitis B Virus Infection in Patients with Systemic Lupus ErythematosusPregnancy-associated thrombotic thrombocytopenic purpura with anti-centromere antibody-positive Raynaud's syndrome.Anti-citrullinated peptide antibodies are the strongest predictor of clinically relevant radiographic progression in rheumatoid arthritis patients achieving remission or low disease activity: A post hoc analysis of a nationwide cohort in Japan.A novel autoantibody against fibronectin leucine-rich transmembrane protein 2 expressed on the endothelial cell surface identified by retroviral vector system in systemic lupus erythematosus.The glycolytic enzyme PKM2 bridges metabolic and inflammatory dysfunction in coronary artery disease.Giant Cell Arteritis: From Pathogenesis to Therapeutic Management.Prognostic Factors Toward Clinically Relevant Radiographic Progression in Patients With Rheumatoid Arthritis in Clinical Practice: A Japanese Multicenter, Prospective Longitudinal Cohort Study for Achieving a Treat-to-Target StrategyA novel autoantibody against ephrin type B receptor 2 in acute necrotizing encephalopathy.Ulcerative keratitis in patients with rheumatoid arthritis in the modern biologic era: a series of eight cases and literature review.Immune checkpoint dysfunction in large and medium vessel vasculitis.Pro-inflammatory and anti-inflammatory T cells in giant cell arteritis.High Prevalence of Acute Exacerbation of Interstitial Lung Disease in Japanese Patients with Systemic Sclerosis.Pyruvate controls the checkpoint inhibitor PD-L1 and suppresses T cell immunity.Extracorporeal Shock Wave Therapy for Digital Ulcers of Systemic Sclerosis: A Phase 2 Pilot Study.Isolated granulomatous renal arteritis: a variant form of giant cell arteritis with few macrophages.Retrospective analysis of 95 patients with large vessel vasculitis: a single center experience.Long-term follow-up of 124 patients with polymyositis and dermatomyositis: Statistical analysis of prognostic factors.Chronic lupus peritonitis is characterized by the ascites with a large content of interleukin-6.Prevalence of hepatitis B virus infection in patients with rheumatic diseases in Tohoku area: a retrospective multicenter survey.Autophagy plays a protective role as an anti-oxidant system in human T cells and represents a novel strategy for induction of T-cell apoptosis.Immunoinhibitory checkpoint deficiency in medium and large vessel vasculitis.Dramatic radiographic repair by tocilizumab in a very elderly patient with rheumatoid arthritis.Prevalence and time course of hepatitis B virus infection in patients with systemic lupus erythematosus under immunosuppressive therapy.Inhibition of JAK-STAT Signaling Suppresses Pathogenic Immune Responses in Medium and Large Vessel Vasculitis.The microvascular niche instructs T cells in large vessel vasculitis via the VEGF-Jagged1-Notch pathway.Evolution of vestibular schwannoma after removal of epidermoid cyst of the same location: case report.Multicenter Double-Blind Randomized Controlled Trial to Evaluate the Effectiveness and Safety of Bortezomib as a Treatment for Refractory Systemic Lupus Erythematosus.Hypermetabolic macrophages in rheumatoid arthritis and coronary artery disease due to glycogen synthase kinase 3b inactivation.Synovitis in a Patient with IgG4-related Disease.Pulmonary hypertension confirmed histologically five months prior to scleroderma renal crisis onset.Successful use of intensive immunosuppressive therapy for treating simultaneously occurring cerebral lesions and pulmonary arterial hypertension in a patient with systemic lupus erythematosus.Glucose metabolism controls disease-specific signatures of macrophage effector functionsMMP (Matrix Metalloprotease)-9-Producing Monocytes Enable T Cells to Invade the Vessel Wall and Cause VasculitisGenetic determinants and an epistasis of LILRA3 and HLA-B*52 in Takayasu arteritis.Severe pharyngeal edema in systemic lupus erythematosusChurg-Strauss syndrome with exophthalmos and orbital bone destructionSuccessful multi-target therapy using corticosteroid, tacrolimus, cyclophosphamide, and rituximab for rapidly progressive interstitial lung disease in a patient with clinically amyopathic dermatomyositisCalcified iliopsoas abscess caused by Enterococcus faecalisGranulomatosis with polyangiitis preceded by central diabetes insipidusPseudothrombocytosis caused by cryoglobulin crystals in a patient with primary Sjögren's syndrome
P50
Q28085459-EBDEC42A-ADA9-423E-82EE-1EC350C819F2Q33390232-5C0DAA20-F605-4701-9375-563FE6A64E2DQ33688001-58BAC3DC-7D24-4832-81EB-7B3A3A28FEDBQ34322432-8D61C3AC-BB91-44CE-AC2B-2095B83438FEQ36745053-BC4BDDA8-4B5E-4351-A2A5-D25FE0085F88Q36992669-67DC3FEB-B2F6-4853-8C7A-2FFD6887B7A8Q37206416-3F0C6DC2-BC78-4B7A-A5B9-57C9B092D943Q37368040-4CC9FEF5-4DD9-4095-9B5B-2215B4EC3764Q38548104-DA817707-1386-4459-885A-E412DC2A7216Q38897019-F55FE071-D1DF-426F-B301-EE1E6B56B48DQ39356029-21F4A66E-852F-4D95-9DF0-52E31AE0E33DQ39528755-367FAC36-E9C3-4486-8C52-903B37982AA3Q40163840-2D41F59F-100A-4827-A992-2D406A82C116Q40338926-5263CFFE-1DB8-4A4D-BC2E-3DA7E913245BQ40368778-906994DA-A589-4371-B699-20E2A8A8D94EQ40459457-6581190D-275B-440E-B71F-5B68349D9EC2Q40901486-DB9926F1-6795-4C2C-9973-998166DFED96Q41376388-F788626D-2962-4BFE-8DF7-CBBFF8F49877Q42214564-491DBA82-2BAF-4DCA-90DD-D63130D455CFQ42220520-DA1FE055-9372-4111-930B-12CEAF0DA31DQ42321741-A5E18F53-F3AE-4587-B3D3-3E4A0989DF42Q42976225-F99AF06A-B3AA-4A82-8C58-4CE01CAE9CC0Q44718415-E04847E6-6806-4189-90F4-65C5A6705EFFQ47279406-93713B53-DCA7-4857-8BDE-1AA096B0A79CQ48099660-1EE91DC1-9470-441C-935A-1C93CAF6F366Q48424728-37863C9B-FAAC-482F-BAA4-B58F92889D70Q49829769-73A276A3-22C5-42B3-B94E-EAF03F1D2D95Q50069479-F3678400-D56C-48CB-A0AC-7276EC74FE56Q53006084-CB1DFE47-842C-4C0C-8626-16FBBC6B356AQ53254264-89727600-50C6-4B6C-A199-F041F46C234FQ53759628-B42C209F-24B8-45A5-A705-CC26FC792756Q58599413-10290494-9C75-436E-9170-9A421F59E18BQ64123933-42BA50DB-7114-4419-8CE4-0AA8A7CABF21Q64885278-A45236C3-99A8-4393-8AED-D8D8295E2313Q84432605-6295A64C-DD70-4A0C-B3EB-DB02A722C8BBQ84583004-88C2AB01-CB42-4A4D-AE64-EF3D163A1EEAQ86778533-ED0CA1B6-868D-427D-BDB3-FB3EE8D439ACQ87299604-60F25721-7C96-47A8-8ED4-5CB60D86085AQ87494594-615A035E-A347-437A-97A2-E449A403D046Q88116047-E9A578C5-CEA6-4C6E-9D06-F0297A73BF86
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Ryu Watanabe
@en
Ryu Watanabe
@nl
type
label
Ryu Watanabe
@en
Ryu Watanabe
@nl
prefLabel
Ryu Watanabe
@en
Ryu Watanabe
@nl
P108
P31
P496
0000-0002-1089-5296